Crosspoint Capital Strategies’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-1,814
Closed -$72K 595
2015
Q4
$72K Buy
1,814
+564
+45% +$21.5K 0.02% 388
2015
Q3
$45K Sell
1,250
-6,018
-83% -$231K 0.05% 266
2015
Q2
$293K Buy
7,268
+5,851
+413% +$254K 0.08% 131
2015
Q1
$61K Sell
1,417
-2,509
-64% -$109K 0.03% 253
2014
Q4
$177K Buy
3,926
+1,117
+40% +$45.5K 0.06% 213
2014
Q3
$108K Sell
2,809
-950
-25% -$38.5K 0.08% 150
2014
Q2
$152K Buy
3,759
+950
+34% +$39.1K 0.06% 153
2014
Q1
$115K Hold
2,809
0.05% 169
2013
Q4
$111K Buy
+2,809
New +$96.6K 0.04% 180

Other funds holding ORCL

Crosspoint Capital Strategies's ORCL Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Oracle (ORCL) in Q1 2016, closing a stake of 1,814 shares — an estimated $72K sold.

Crosspoint Capital Strategies first reported a position in ORCL in Q4 2013 and held it in 9 quarters. The position peaked at $293K in Q2 2015. 1,521 funds tracked by Wall St. Rank hold ORCL as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining Oracle position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 1,814 Oracle shares in Q1 2016, an estimated $72K.
  • Crosspoint Capital Strategies first reported a position in Oracle in Q4 2013 and held it in 9 quarters.
  • Crosspoint Capital Strategies's Oracle position peaked at $293K in Q2 2015.
  • 1,521 funds tracked by Wall St. Rank held Oracle as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.